Effect of antilymphocyte serum on reovirus infection of mice

S Ida1, Y Hinuma

  • 1Department of Microbiology, Tohoku University School of Dentistry, Sendai 980, Japan.

Infection and Immunity
|February 1, 1971
PubMed

Insights

Antilymphocyte serum (ALS) can induce acute reovirus type 3 disease in older mice. This suggests ALS may suppress cellular immunity, making mice susceptible to viral infections.

Area of Science:

  • Virology
  • Immunology
  • Pathology

Background:

  • Reovirus type 3 infection causes acute disease in young mice.
  • Older mice (≥7 days) are typically resistant to this acute disease.

Purpose of the Study:

  • To investigate the effect of antilymphocyte serum (ALS) on reovirus type 3 infection in mice.
  • To explore the role of cellular immunity in reovirus-induced disease.

Main Methods:

  • Mice of different ages were inoculated with reovirus type 3.
  • Some mice received antilymphocyte serum (prepared from rabbit anti-mouse thymocytes) before virus inoculation.
  • Disease manifestation was observed and compared between groups.

Main Results:

  • Younger mice (<5 days) developed acute disease upon reovirus inoculation.
  • Older mice (≥7 days) did not develop acute disease when inoculated with reovirus alone.
  • A single injection of ALS followed by reovirus inoculation induced acute disease in older mice (≥7 days).

Conclusions:

  • Antilymphocyte serum can render older mice susceptible to acute reovirus type 3 disease.
  • This susceptibility is likely due to the suppression of a cellular immune mechanism targeted by ALS.
  • Cellular immunity plays a critical role in controlling reovirus infections in mice.

Related Concept Videos